DigestRedComo funciona
Red
/
Empresas
JC
No verificado

JCR Pharmaceuticals Co., Ltd.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaIndustriaSalud

30 Comunicados de prensa

Ver todos los comunicados de prensa
07/10/2025
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Eventos
Ferias y Congresos
Industria
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
01/10/2025
Biotecnología
Farmacéutica
Salud
Mercado laboral
Industria
JCR Pharmaceuticals Announces Licensing Agreement with Menagen to Commercialize Agalsidase Beta BS I.V. Infusion [JCR] Across Nine MENAT Markets
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
30/09/2025
Salud
Biotecnología
Sanidad
Ciencia
Farmacéutica
Eventos
Ferias y Congresos
Industria
JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
29/09/2025
Multimedia
Salud
Ciencia
Sanidad
Farmacéutica
Industria
Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by Ministry of Health, Labour and Welfare of Japan
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
19/09/2025
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Industria
JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
12/09/2025
JCR Pharmaceuticals Celebrates its 50th Anniversary of Advancing Science and Changing Lives
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
08/09/2025
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
Industria
JCR Pharmaceuticals Presents Long-Term Clinical Data on Pabinafusp Alfa for the Treatment of Mucopolysaccharidosis Type II (MPS II) at ICIEM 2025
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
02/09/2025
Multimedia
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Sanidad
Salud
Medicina - Varios
MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
28/08/2025
Ciencia
Biotecnología
Farmacéutica
Medicina - Varios
Sanidad
Salud
Material médico sanitario
Eventos
Industria
JCR Pharmaceuticals to Present at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) 2025
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0
16/07/2025
Biotecnología
Farmacéutica
Salud
Industria
JCR Pharmaceuticals Selected for Japan’s Regenerative Medicine CDMO Subsidy Program
Fuente
JCR Pharmaceuticals Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0